Harry Eagle Postdoctoral Scholar

Dr. Harry Eagle was the founding Chair of the Department of Cell Biology and the first Director of the Albert Einstein Cancer Center. He was a hugely influential and visionary leader in the early years of our medical school. As a medical scientist, Dr. Eagle published prolifically and made many important discoveries in medicine. His best-known achievement was his formulation of the Eagle’s medium in 1959, which ushered in the era of animal cell culture and in vitro cell studies in modern medicine. By naming the department’s most distinguished Postdoctoral Scholarship after Dr. Eagle, we seek to identify exceptional young researchers who have shown clear evidence of scientific productivity and excellence and would like to further develop their career by joining our highly dynamic and stimulating research community. Our goal is to inspire and cultivate tomorrow’s science innovators and leaders who will follow in the footsteps of Dr. Eagle and pioneer new science.

Stipend $75,000/year

Applicants should be within 2 years of the completion of their PhD or MD-PhD degree and have a proven track record of excellence in research. The Department of Cell Biology and the Albert Einstein College of Medicine offer outstanding state-of-the-art facilities to conduct molecular and cellular biology studies. The College offers subsidized housing. The award is for two years with eligibility for a third year.

The following faculty are part of the program:

  • Julio Aguirre-Ghiso

    Julio Aguirre-Ghiso

    Cancer Dormancy: understanding the biology of Metastasis
  • Leonard Augenlicht

    Leonard Augenlicht

    Nutritional and genetic regulation of intestinal homeostasis and stem cell functions.
  • Eric Bouhassira

    Eric Bouhassira

    Stem cell biology, epigenetics, erythropoiesis, DNA replication.
  • Robert Coleman

    Robert Coleman

    Human tumorigenesis is a complicated process marked by a loss of the cell’s ability to regulate critical cellular processes, such as transcription, RNA processing and translation, leading to uncontrollable cell growth.
  • John Codeeli

    John Codeelis

    Interests are in optical physics, cell biology and biophysics, cancer biology and mouse models of cancer. Development of the multiphoton imaging technology used to identify intravasation microenvironments in metastatic tumors.
  • Winfried Edelmann

    Winfried Edelmann

    Mouse models to study DNA repair genes in cancer and meiosis.
  • Dmitry Fyodorov

    Dmitry Fyodorov

    Chromosome assembly and dynamics; ATP-dependent nucleosome remodeling; histone chaperones; sperm chromatin; Drosophila melanogaster.
  • Matthew Gamble

    Matthew Gamble

    Regulation of chromatin structure and function during cancer and senescence by the histone variant macroH2A.
  • Kira Gritsman

    Kira Gritsman

    The P13 Kinase signaling pathway in adult blood development and leukemia.
  • Kira Gritsman

    Wenjun Guo

    Regulation of stem-cell states in the mammary gland and breast cancer.
  • Keisuke Ito

    Keisuke Ito

    Biomedical research aiming toward the development of stem cell therapies.
  • Keisuke Ito

    Margaret Kielian

    Virus assembly and budding; host factors in virus infection; virus-membrane fusion.
  • Richard Kitsis

    Richard Kitsis

    Fundamental mechanisms of cell death and their application to heart disease and cancer.
  • Lindsay Lafave

    Lindsay LaFave

    Our lab uses state-of-the art epigenomic approaches to examine gene regulatory programs that drive cellular diversity in lung cancer progression.
  • Tom Meier

    Thomas Meier

    Our group is studying the mechanism and regulation of nucleolar ribonucleoprotein biogenesis in relation to genetic disease, cancer, and human reproduction.
  • Maria Marianovich

    Hematopoietic stem cell and cancer stem cell microenvironment. Our lab studies mechanisms that regulate the maintenance of bone marrow niches for hematopoietic stem cells during homeostasis, aging, or myeloid malignancy.
  • Satish Nandakumar

    Satish Nandakumar

    Genetics of Blood Cancer Predisposition.
  • Charles Query

    Charles Query

    Mechanism and modulation of spliceosome function.
  • Rebeca San Martin

    Rebeca San Martin

    Prostate cancer microenvironment. Bone metastasis and dormancy. Development of alternative in-vitro systems that model progression and metastasis.
  • Matthew Scharff

    Matthew Scharff

    Molecular basis of mutation and switching of immunoglobulin genes and use of monoclonal antibodies in infections.

  • Carl Schildkraut

    Carl Schildkraut

    Role of dynamic DNA structures in the etiology of cancer, fragile X syndrome and telomere dysfunction. Projects include studies in embryonic stem cells.
  • Robert Singer

    Robert Singer

    RNA trafficking
  • Arthur Skoultchi

    Arthur Skoultchi

    Chromatin structure and function; normal and malignant hematopoiesis; cell cycle regulation; embryonic stem cells and knock-out mice.
  • Pamela Stanley

    Pamela Stanley

    Functions of mammalian glycans in development, spermatogenesis and Notch signaling.
  • Ulrich Steidl

    Ulrich Steidl

    Transcriptional dysregulation of pre-leukemic cell states and their therapeutic targeting.
  • Britta Will

    Britta Will

    Mechanisms of stem cell aging and transformation.
  • Kristy Stengel

    Kristy Stengel

    Deregulated gene expression is a hallmark of cancer. Our goal is to understand how recurrent alterations in transcription factor proteins (e.g. mutation, translocation) disrupt normal gene expression networks to trigger cancer development.
  • B. Hilda Ye

    B. Hilda Ye

    Oncogenes in the development of normal and malignant B cells.

Interested individuals should contact one of the above faculty members at Department of Cell Biology, Albert Einstein College of Medicine, Jack and Pearl Resnick Campus, 1300 Morris Park Avenue, New York, NY 10461. Applications should consist of a CV and three letters of recommendation and are evaluated throughout the year.